The Australian medical landscape is buzzing with the emergence of retatrutide, a novel dual GIP and GLP-1 receptor showing impressive results in early trials for treating obesity. This treatment promises a https://linkedbookmarker.com/story7410575/retatrutide-australia-a-emerging-hope-for-weight-management